Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers

Clinical trial NCT04747054 · RECRUITING

Trial details

NCT number: NCT04747054
Sponsor: UNICANCER
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of Head and Neck

Start date: 2021-12-01
Primary completion: 2026-10-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.